Pharmaceutical manufacturers of Amphotericin b

Xellia is a specialty pharmaceutical company focusing on providing anti-infective treatments and other critical care therapies for serious and often life-threatening conditions.

Fagron aims to enhance and revolutionize individualized pharmaceutical care. Established in 1990 in Rotterdam, the Netherlands, Fagron has achieved market leadership in pharmaceutical compounding by prioritizing innovation, quality, and problem-solving. Fagron's dedicated team is engaged in the development, innovation, and manufacturing of original concepts, products, and formulas for compounding pharmacies, prescribers, and patients across 35 nations worldwide. With over 2,600 employees situated in offices, compounding facilities, and plants in Fagron's key regions in the Benelux, Europe, North America, South America, and the Pacific.

Pfizer CentreOne® is a completely distinct global contract development and manufacturing organization (CDMO), as well as a prominent provider of specialty APIs and intermediates. Supported by resources from Pfizer, we have provided technical knowledge, regulatory assistance, and long-term supply for more than 40 years. With a network of over 35 sites spanning six continents, we are capable of securely and effectively guiding complex compounds from development to commercial manufacture. For more details, please visit http://www.pfizercentreone.com

The Ajinomoto Group has advanced its purpose from “Unlocking the power of amino acids to resolve the food and health issues” to “contributing to the well-being of all human beings, our society and our planet with ‘AminoScience’.” We consider well-being to mean health and happiness. Our advanced purpose therefore represents our commitment to achieving two outcomes by 2030 which are connected by food systems: to reduce our environmental impact by 50% and to help extend the healthy life expectancy of 1 billion people.

ACS DOBFAR, an Italian firm established in 1973, is a privately owned business that serves as a fully integrated producer of Cephalosporin and Penicillin APIs as well as Finished Dosage Formulations. With manufacturing facilities located across the globe routinely examined by the US FDA, it stands as a prominent company among suppliers to the US market.

NCPC International Corp. is a platform for international trade of NCPC and the exclusive channel for exporting the preparations of NCPC, the business scope covers import and export trade, CMO, technology transfer and pharmaceutical logistics in domestic. NCPC International Corp. provides all-around and one-stop sales and service on APIs, preparations, medical equipments and consumables, based on creating more values for foreign customers. NCPC International Corp. has been exporting to more than 80 countries and regions, increasing the overseas sales yearly, ranking 1st on exporting preparations in china mainland for last continuous 3 years. NCPC International Corp. is a worldwide supplier of generic pharmaceuticals. As an Anti-infective expert and your local one- stop partner NCPC International Corp. will provide you the most comprehensive products and the most professional and efficient services. We are sincerely expecting to cooperate with friends from all sectors for shared development and a brighter future!

We are a global vertically integrated pharmaceutical company engaged in research and development, manufacture, sale and distribution of prescription and OTC pharmaceutical products, with global presence in more than 50 countries, including United States, Europe, Canada, Japan, Australia and Rest of the World. We offer a wide range of proprietary finished dosage formulation catering to different therapeutic segments, including CVS, CNS, gastro-intestinal, etc. in multiple dosage forms including: Immediate-release oral solids Modified release oral solids MUPS based products Chewable tablets Powder for oral solutions & Suspensions

Jubilant HollisterStier Contract Manufacturing & Services is a fully integrated contract manufacturer that specializes in producing sterile injectables, ophthalmics, otics, and sterile and non-sterile topicals and liquids. Their facilities in North America and India offer specialized manufacturing services for the pharmaceutical and biopharmaceutical industries, with a strong emphasis on maintaining high-quality standards throughout their operations. They also provide a comprehensive range of support and services to optimize the manufacturing process, including on-site assistance for process qualifications and regulatory submittals.

Zhejiang Tiantai Pharmaceutical Co., Ltd. (listed), founded in June 1998, is specialized in R&D, manufacturing and sales of antifungal and antibiotics series featured APIs products including Clindamycin Hydrochloride, Clindamycin Phosphate and Amphotericin B, and the CRO&CDMO business of APIs. The company is one of the major manufacturers of Clindamycin Hydrochloride and Clindamycin Phosphate at home and abroad. Focusing on the big health industry, the company has built the traditional featured APIs and API CDMO&CRO business plate and synthetic biology drugs plate. Relying on the advantages of existing products, technologies, teams and platforms, the company become a low-cost, scaled, APIs-and-preparations integrated manufacturing base of featured generic drugs, and gradually developed towards the innovative drugs.

ASENCE PHARMA PVT. LTD. functions as a subsidiary of ASENCE INC. USA - a pharmaceutical company based in New York. The company specializes in providing high-quality pharmaceutical products such as API’s, finished dosage formulations, and effervescent products to global markets. ASENCE PHARMA PVT. LTD. is affiliated with the ‘’SARABHAI’’ Group of Companies.

TOT BIOPHARM is a biopharmaceutical organization in the clinical development stage, dedicated to the advancement and commercialization of innovative oncology medications and therapies. Our goal is to establish a prominent brand in oncology treatments that is trusted by patients, their families, and healthcare professionals in China.